ENANTA PHARMACEUTICALS INC
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 16, 2026 (20 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 23, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 23, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Feb 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Jan 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Nov 14, 2025 | JP Morgan | initiate | — → Overweight | $17 | 55% |
| Sep 30, 2025 | WestPark Capital | maintain | Buy → Buy | $28 | 51% |
| Sep 15, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $12 | 58% |
| Sep 2, 2025 | WestPark Capital | initiate | — → Buy | $24 | 51% |
| Aug 12, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $25 | 53% |
| Jun 3, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $24 | 53% |
| May 14, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $23 | 53% |
| Feb 11, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $21 | 53% |
| Feb 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Dec 24, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $18 | 44% |
| Nov 26, 2024 | Baird | maintain | Outperform → Outperform | $20 | 55% |
| Nov 26, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $21 | 53% |
| Oct 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $27 | 44% |
| Oct 9, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $22 | 53% |
| Sep 27, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $22 | 53% |
| Aug 6, 2024 | JP Morgan | maintain | Underweight → Underweight | $10 | 55% |
| Aug 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $27 | 44% |
| May 7, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $27 | 44% |
| May 7, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $22 | 53% |
| Feb 8, 2024 | JP Morgan | maintain | Underweight → Underweight | $11 | 55% |
| Nov 22, 2023 | Oppenheimer | maintain | Perform → Perform | $21 | 52% |
| Nov 21, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $28 | 44% |
| Nov 21, 2023 | JMP Securities | maintain | Outperform → Outperform | $23 | 53% |
| Oct 23, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $30 | 44% |
| Oct 2, 2023 | RBC Capital | maintain | Sector Perform → Sector Perform | $15 | 55% |
| Sep 19, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $48 | 44% |
| Aug 9, 2023 | Oppenheimer | maintain | Perform → Perform | $25 | 52% |
| Aug 8, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $48 | 44% |
| Aug 8, 2023 | RBC Capital | reiterate | Sector Perform → Sector Perform | $25 | 55% |
| Aug 8, 2023 | JMP Securities | maintain | Market Outperform → Market Outperform | $42 | 53% |
| Aug 8, 2023 | Jefferies | downgrade | Buy → Hold | $18 | 51% |
| May 11, 2023 | Oppenheimer | reiterate | Perform → Perform | $30 | 52% |
| May 9, 2023 | RBC Capital | maintain | — → Sector Perform | $33 | 55% |
| May 9, 2023 | HC Wainwright & Co. | maintain | — → Buy | $48 | 44% |
| May 9, 2023 | JMP Securities | maintain | — → Outperform | $65 | 53% |
| Mar 22, 2023 | RBC Capital | reiterate | — → Sector Perform | $54 | 55% |
| Feb 9, 2023 | SVB Leerink | reiterate | — → Market Perform | $49 | — |
| Feb 8, 2023 | Piper Sandler | maintain | — → Overweight | $87 | 54% |
| Feb 8, 2023 | JP Morgan | maintain | — → Neutral | $60 | 55% |
| Jan 27, 2023 | SVB Leerink | maintain | — → Market Perform | $49 | — |
| Dec 9, 2022 | HC Wainwright & Co. | initiate | — → Buy | $56 | 44% |
| Nov 22, 2022 | RBC Capital | maintain | — → Sector Perform | $54 | 55% |
| Aug 10, 2022 | Oppenheimer | maintain | — → Perform | $59 | 52% |
| Aug 9, 2022 | JMP Securities | maintain | — → Market Outperform | $137 | 53% |
| Aug 9, 2022 | RBC Capital | maintain | — → Sector Perform | $66 | 55% |
| Aug 1, 2022 | Oppenheimer | maintain | — → Perform | $53 | 52% |
No cross-platform signals in the last 90 days